Joseph Stringer

Stock Analyst at Needham

(0.37)
# 2100
Out of 5,218 analysts
282
Total ratings
36.44%
Success rate
8.13%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
Phathom Pharmaceutic...
Reiterates: Buy
28 28
7.87 255.78% 46 Dec 11, 2024
Lexicon Pharmaceutic...
Reiterates: Hold
n/a
n/a n/a 9 Nov 25, 2024
Vir Biotechnology
Reiterates: Buy
19 19
7.46 154.69% 15 Nov 20, 2024
Annexon
Reiterates: Buy
16 16
4.46 258.74% 17 Nov 15, 2024
Avidity Biosciences
Reiterates: Buy
60 60
32.5 84.62% 15 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
36.62 63.84% 16 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
55 64
55.28 15.77% 18 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140 140
87.74 59.56% 12 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 60
33.24 80.51% 19 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
12.05 82.57% 18 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23 23
3.02 661.59% 16 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
320 320
245.25 30.48% 16 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
23.25 7.53% 8 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 38
13.2 187.88% 14 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 2 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
17.3 113.87% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
9.87 82.37% 2 Aug 24, 2021